Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.23.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2023
Stockholders’ Equity [Abstract]  
Schedule of warrant and stock option grants with time-based vesting
    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of shares subject to warrants     Weighted-average exercise price per share     Number of shares subject to options     Weighted-average exercise price per share     Number of shares subject to restricted stock units  
Balance at December 31, 2022     1,567,720     $ 1.35       118,388     $ 3.25       2,409,759  
Granted    
-
     
-
     
-
     
-
      340,000  
Exercised    
-
     
-
     
-
     
-
      (11,332 )
Cancelled/Expired     (21,688 )     8.33      
-
     
-
     
-
 
Balance at March 31, 2023     1,546,032     $ 1.24       118,388     $ 3.25       2,738,427  
Exercisable at March 31, 2023     1,546,032     $ 1.24       118,388     $ 3.25       2,412,135  

Schedule of company’s outstanding warrants and options
Warrants Outstanding     Warrants Exercisable  
Exercise Price Range     Number
Outstanding
    Weighted Average
Remaining
Contractual Life
(in years)
    Weighted 
Average Exercise Price
    Number
Exercisable
    Weighted Average
Exercise Price
    Intrinsic Value  
$0.65 - $20.90          1,546,032       2.35     $ 1.24       1,546,032     $ 1.24      
-
 

 

Options Outstanding     Options Exercisable  
Exercise Price Range     Number
Outstanding
    Weighted Average
Remaining
Contractual Life
 (in  years)
    Weighted 
Average Exercise Price
    Number
Exercisable
    Weighted Average
Exercise Price
    Intrinsic Value  
$2.64 - $6.84       118,388       1.44     $ 3.25       118,388     $ 3.25      
-
 

Schedule of stock-based compensation expense
    For the three months ended  
    March 31,  
    2023     2022  
Stock-based compensation expense   $ 147,873     $ 347,568  

Schedule of stock-based compensation expense categorized by the equity components
    For the three months ended  
    March 31,  
    2023     2022  
Common stock   $ 147,873     $ 347,568  
Total   $ 147,873     $ 347,568